News und Analysen
Cocrystal Pharma Narrows Loss in Q2
Cocrystal Pharma (NASDAQ:COCP), a clinical-stage biotech focusing on antiviral drug development, released its second quarter 2025 earnings on August 14, 2025. The company’s report highlighted a
CoreCard Revenue Jumps 28 Percent in Q2
CoreCard (NYSE:CCRD), a provider of financial technology software and services, delivered its second quarter 2025 earnings on August 14, 2025. The main highlight was a surge in both revenue and
Galectin Beats Q2 Loss Estimates
Galectin Therapeutics (NASDAQ:GALT), a clinical-stage biotech firm focused on liver fibrosis and cancer, reported its second quarter 2025 results on August 14, 2025. The most significant news was a
Qxo Posts 1,906 Million Revenue in Q2
Qxo (NYSE:QXO), a rapidly transforming distributor of building products, released its second quarter earnings for fiscal 2025 on August 14, 2025. The most notable news was that it recorded Adjusted
FitLife Brands Reports 5 Percent Q2 Drop
FitLife Brands (NASDAQ:FTLF), a nutritional supplements company with products spanning sports nutrition, weight management, and general wellness, released its financial results for the second
Atai Life Sciences Revenue Jumps 163%
Atai Life Sciences (NASDAQ:ATAI), a biotechnology company developing novel treatments for mental health conditions, reported its results for the second quarter of fiscal 2025 on August 14, 2025. The
Werewolf Reports No Revenue in Fiscal Q2
Werewolf Therapeutics (NASDAQ:HOWL), an early-stage biotechnology company dedicated to innovative cancer immunotherapies, reported its second quarter 2025 results on August 14, 2025. The main story
Bk Technologies EPS Jumps 136 Percent
Bk Technologies (NYSEMKT:BKTI), a public safety radio and communications equipment provider, released its second quarter fiscal 2025 results on August 14, 2025. The company posted a major earnings
Protalix Revenue Jumps 16 Percent in Q2
Protalix BioTherapeutics (NYSEMKT:PLX), a biopharmaceutical company specializing in plant cell-based protein production, announced its second quarter results on August 14, 2025. Revenues from
Deere Beats Fiscal Q3 EPS as Sales Fall
Deere & Company (NYSE:DE), a leading manufacturer of agricultural, construction, and forestry equipment, reported results for fiscal Q3 2025 (ended July 27, 2025) on August 14, 2025. The company
BCG Reports Earnings
Binah Capital Group (NASDAQ:BCG), a wealth management and brokerage platform serving financial advisors and their clients, released its second quarter 2025 financial results on August 13, 2025. In
3 Reasons to Buy Chevron Stock Like There's No Tomorrow
Chevron (NYSE: CVX) is at a pivotal moment. The oil giant is on the cusp of a major free-cash-flow surge. It has also significantly enhanced its long-term growth trajectory through a series of
EQS-News: Half-year results: PNE AG reports operational success in H1
Applied Therapeutics Reports Q2 Loss
Applied Therapeutics (NASDAQ:APLT), a biotechnology company focused on developing treatments for rare metabolic diseases, reported earnings results for Q2 2025 on August 13, 2025. The main news from
Ibotta Posts 2 Percent Sales Decline
Ibotta (NYSE:IBTA), a leading digital promotions and performance marketing platform for consumer packaged goods (CPG), released financial results for Q2 2025 on August 13, 2025. The most notable
Natural Gas Services Group Beats Q2 EPS
Natural Gas Services Group (NYSE:NGS), a provider of natural gas compression equipment rentals and services, Natural Gas Services Group released its financial results for Q2 FY2025 on August 11
Acrivon Posts Narrower Loss in Q2
Acrivon Therapeutics (NASDAQ:ACRV), a clinical-stage biotech developing precision oncology medicines, released its second quarter 2025 results on August 13, 2025. The report showed a GAAP net loss
Tenax Posts Wider Loss in Fiscal Q2
Tenax Therapeutics (NASDAQ:TENX), a development-stage biopharmaceutical company focused on treatments for cardiovascular and pulmonary diseases, released its results for the second quarter of fiscal
Fossil Posts Narrower Loss in Q2
Fossil Group (NASDAQ:FOSL), known for its portfolio of fashion watches and accessories, reported its latest quarterly results on Aug. 13, 2025. The most notable news in the release was a
Alto Neuroscience Posts Q2 Net Loss
Alto Neuroscience (NYSE:ANRO), a clinical-stage biotechnology company focused on precision psychiatry, released its second-quarter results on August 13, 2025. It reported a net loss of $17.7
Red Robin Swings to Profit in Fiscal Q2
Red Robin Gourmet Burgers (NASDAQ:RRGB), a family-friendly, casual-dining chain known for gourmet burgers and bottomless sides, released its fiscal second quarter 2025 results on August 13, 2025
Jade Biosciences Posts Wider Loss in Q2
Jade Biosciences (NASDAQ:JBIO), a biotechnology company focused on autoimmune disease therapies, published its results on August 13, 2025. The standout message: the company reported a GAAP net loss
Barfresh Reports 11% Revenue Gain in Q2
Barfresh Food Group (NASDAQ:BRFH), a provider of ready-to-drink and frozen beverage products often found in schools and institutional settings, released earnings for the second quarter of fiscal
Lumentum Q4 Revenue and Margins Surge
Lumentum(NASDAQ:LITE) reported fourth quarter fiscal 2025 results on August 12, 2025, with non-GAAP revenue of $480.7 million and non-GAAP EPS of $0.88, both exceeding the high end of guidance. The
Spectral Ai Posts 32% Revenue Drop in Q2
Spectral Ai (NASDAQ:MDAI), a medical technology company specializing in wound care diagnostics, reported its second quarter 2025 results on August 13, 2025. The big news of the release was the